Clinical Trial Update: Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults [Phase 4]

View source ↗

Summary

This Phase 4 trial reports pharmacokinetic data for a single IV dose of tedizolid phosphate in morbidly obese and non-obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Tedizolid Phosphate (tedizolid phosphate)

Snippet

Sponsor: Amit.Pai | Conditions: Obesity | Phase 4 | Status: COMPLETED | Results posted: 2017-03-15